A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity.

Esquenazi A, Wein TH, Verduzco-Gutierrez M, Ayyoub Z, Page S, Harding S, Maisonobe P, Beneteau M, Patel A, DIRECTION study group

Open source

DOI
10.1007/s12325-026-03635-y
Published
2026 Aug
Container
Advances in therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03635-y,
  title = {A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity.},
  author = {Esquenazi A and Wein TH and Verduzco-Gutierrez M and Ayyoub Z and Page S and Harding S and Maisonobe P and Beneteau M and Patel A and DIRECTION study group},
  year = {2026},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-026-03635-y},
  url = {https://doi.org/10.1007/s12325-026-03635-y}
}

RIS

TY  - JOUR
TI  - A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity.
AU  - Esquenazi A
AU  - Wein TH
AU  - Verduzco-Gutierrez M
AU  - Ayyoub Z
AU  - Page S
AU  - Harding S
AU  - Maisonobe P
AU  - Beneteau M
AU  - Patel A
AU  - DIRECTION study group
PY  - 2026
JO  - Advances in therapy
DO  - 10.1007/s12325-026-03635-y
UR  - https://doi.org/10.1007/s12325-026-03635-y
ER  - 

APA

A, E., TH, W., M, V., Z, A., S, P., S, H., P, M., M, B., A, P., & group, D. S. (2026). A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity.. Advances in therapy. https://doi.org/10.1007/s12325-026-03635-y

Source records